Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06448637 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later May 1, 2026 → Dec 1, 2026
See other at-risk trials from Fundación EPIC

Record History

  1. Primary endpoints: details revised at 1 of 1 entry Study sites: 8 to 9 · Eligibility criteria expanded, about 7 words · Publications: details revised at 4 of 5 entries Show 3 more changesShow less
    • Study sites: 8 to 9
    • Eligibility criteria expanded, about 7 words
    • Publications: details revised at 4 of 5 entries
  2. Primary completion pushed from May 1, 2026 to Dec 1, 2026 Completion pushed from May 1, 2027 to Dec 1, 2027 · Study sites: 7 to 8v10 Show 2 more changesShow less
    • Completion pushed from May 1, 2027 to Dec 1, 2027
    • Study sites: 7 to 8
  3. Study sites: 6 to 7v9
  4. Study sites: 5 to 6v8
  5. Study sites: 4 to 5v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 3 to 4v6
  2. Study sites: 2 to 3v5
  3. Study sites: 1 to 2v4
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jun 30, 2024 to Oct 23, 2024 · Study sites: 0 to 1v3 Show 2 more changesShow less
    • Start date changed from estimate of Jun 30, 2024 to Oct 23, 2024
    • Study sites: 0 to 1
  5. Primary endpoint revised Secondary endpoints revised (5)v2 Show 1 more changeShow less
    • Secondary endpoints revised (5)

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Randomized, controlled, open and multicenter study that analyzes the vasomotor function 8 months after use of the drug-eluting balloon (DCB) vs. drug-eluting stent (DES) in vessels ≥ 3.5 mm
Trial Details
NCT Number NCT06448637
Lead Sponsor Fundación EPIC
Conditions Coronary Artery Disease
Enrollment 94 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov